The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer
- PMID: 12793900
- PMCID: PMC165007
- DOI: 10.1186/bcr593
The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer
Abstract
Testosterone binds to the androgen receptor in target tissue to mediate its effects. Variations in testosterone levels and androgen receptor activity may play a role in the etiology of breast cancer. Here, we review the epidemiologic evidence linking endogenous testosterone to breast cancer risk. Paradoxically, results from observational studies that have examined polymorphisms in the androgen receptor suggest that the low-activity androgen receptor increases breast cancer risk. We review the quality of this evidence and conclude with a discussion of how the androgen receptor and testosterone results coincide.
References
-
- Norman AW, Litwack G. Hormones. San Diego, CA: Academic Press; 1987.
-
- Longcope C, Franz C, Morello C, Baker R, Johnston CC., Jr Steroid and gonadotropin levels in women during the perimenopausal years. Maturitas. 1986;8:189–196. - PubMed
-
- Abraham GE. Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. J Clin Endocrinol Metab. 1974;39:340–346. - PubMed
-
- Adashi EY. The climacteric ovary as a functional gonadotropin-driven androgen-producing gland. Fertil Steril. 1994;62:20–27. - PubMed
-
- Judd HL, Lucas WE, Yen SS. Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol. 1974;118:793–798. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
